A new Cambridge Enterprise Initiative called Leaps is launching today to embed Cambridge-based companies in complementary ecosystems, giving selected founders access to new markets, talent and investment in key geographical hotspots to enable their success
The initiative has been launched in collaboration with global partners Phoenix Court, Balderton Capital and the BioInnovation Institute Foundation (BII). With space for three companies, the London Leap will allow Cambridge startups to be embedded within the dynamic London ecosystem, which attracts not only international capital, but has a reputation for continued unicorn creation.
With Cambridge being ranked as one of the world’s top cities for innovation output per capita in the Ecosystem Index, behind only the Bay Area and Boston, the deep connection with London will connect two powerful and complementary ecosystems.
The aim is to boost Cambridge-born companies, translating the world-renowned research at the University of Cambridge addressing some of the major global challenges – climate health, human health and quantum computing to name just a few.
Since 1995, the companies supported by Cambridge Enterprise have collectively raised over £4.9bn, making Cambridge a source of trusted commercial science-based innovation. From idea development to investment, we provide the diverse support needed by researchers, innovators and talented teams tackling the challenges facing the world today. Notable spinouts from Cambridge Enterprise include BlueGnome, Centessa Pharmaceuticals, Gyroscope, Solexa, VocalIQ and Cytora.
